Federal Register / Vol. 87, No. 113 / Monday, June 13, 2022 / Notices 35791 

considered the request and is extending 

the comment period for the request for 

comments for 90 days, until September 

14, 2022. The Agency believes that a 90- 

day extension allows adequate time for 

interested persons to submit comments. 

Dated: June 7, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–12621 Filed 6–10–22; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Listing of Members of the 

National Institutes of Health’s Senior 

Executive Service 2022 Performance 

Review Board (PRB) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Institutes of 

Health (NIH) announces the persons 

who will serve on the National 

Institutes of Health’s Senior Executive 

Service 2022 Performance Review 

Board. 

FOR FURTHER INFORMATION CONTACT: For 

further information about the NIH 

Performance Review Board, contact Mr. 

Kha Nguyen, Director, Division of 

Senior and Scientific Executive 

Management, Office of Human 

Resources, National Institutes of Health, 

Building 31, Room 1C31P, Bethesda, 

Maryland 20892, telephone 

301.594.3022 (not a toll-free number), 

email kha.nguyen@nih.gov. 

SUPPLEMENTARY INFORMATION: This 

action is being taken in accordance with 

Title 5, U.S.C., Section 4314(c)(4), 

which requires that members of 

performance review boards be 

appointed in a manner to ensure 

consistency, stability, and objectivity in 

performance appraisals and requires 

that notice of the appointment of an 

individual to serve as a member be 

published in the Federal Register. 

The following persons will serve on 

the NIH Performance Review Board, 

which oversees the evaluation of 

performance appraisals of NIH Senior 

Executive Service (SES) members: 

Alfred Johnson, Chair 

Michael Gottesman 

Darla Hayes 

Michael Lauer 

Kathleen Stephan 

Vicki Buckley 

Rodney Rivera 

Tara Schwetz 

Dated: June 6, 2022. 

Tara A. Schwetz, 

Acting Principal Deputy Director, National 

Institutes of Health. 

[FR Doc. 2022–12603 Filed 6–10–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID Investigator Initiated 

Program Project Applications (P01 Clinical 

Trial Not Allowed). 

Date: July 12, 2022. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G45, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Vanitha S. Raman, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G45, Rockville, MD 

20852, 301–761–7949, vanitha.raman@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: June 7, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–12665 Filed 6–10–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF THE INTERIOR 

Bureau of Land Management 

[LLMTL01000–L161000000.PN0000–223; MO 

#4500161643; MTM–89170–02] 

Notice of Proposed Withdrawal and 

Public Meeting; Montana 

Correction 

In notice document 2022–12103 

beginning on page 34289 in the issue of 

Monday, June 6, 2022, make the 

following correction: 

On page 34290, in the first column, in 

the sixth paragraph, starting on the first 

line ‘‘For a period until June 6, 2024 

including location and entry under the 

United States mining laws, but not from 

leasing under the mineral leasing and 

mineral materials disposal laws, subject 

to valid existing rights, unless the 

application is denied or canceled, or the 

withdrawal is approved prior to that 

date.’’ should read ‘‘For a period until 

June 6, 2024, the public lands described 

earlier will be segregated from all forms 

of appropriation under the public land 

laws, including location and entry 

under the United States mining laws, 

but not from leasing under the mineral 

leasing and mineral materials disposal 

laws, subject to valid existing rights, 

unless the application is denied or 

canceled, or the withdrawal is approved 

prior to that date.’’ 

[FR Doc. C1–2022–12103 Filed 6–10–22; 8:45 am] 

BILLING CODE 1505–01–D 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1319] 

Certain Electronic Devices and 

Semiconductor Devices With TimingAware Dummy Fill and Components 

Thereof; Institution of Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that a 

complaint was filed with the U.S. 

International Trade Commission on 

April 22, 2022, under section 337 of the 

Tariff Act of 1930, as amended, on 

behalf of Bell Semiconductor, LLC of 

Bethlehem, Pennsylvania. The 

complaint was supplemented on May 6, 

2022, May 13, 2022, and May 19, 2022 

(as revised on May 25, 2022). The 

complaint, as supplemented, alleges 

violations of section 337 based upon the 

importation into the United States, the 

sale for importation, and the sale within 

the United States after importation of 


khammond on DSKJM1Z7X2PROD with NOTICES